Nelarabine 5 mg/mL
Nelarabine · INJECTION · Gland Pharma Limited
Nelarabine is a nucleoside metabolic inhibitor given by intravenous injection that is used to treat certain types of leukemia and lymphoma, particularly in patients who have not responded to other treatments. It works by interfering with cancer cell growth and division.
Key Facts
- Brand Name
- Nelarabine
- Generic Name
- Nelarabine
- NDC Code (Product)
68083-233- Manufacturer
- Gland Pharma Limited
- Strength
- 5 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- ANDA212605
- Drug Class
- Nucleoside Metabolic Inhibitor [EPC]
- Marketing Start
- 01/03/2024
Recall History
Zydus Pharmaceuticals (USA) Inc
Failed Impurities/Degradation Specifications
GlaxoSmithKline, LLC.
Impurities/Degradation Products: Potential for drug related impurities to exceed the specification limits.
Zydus Pharmaceuticals (USA) Inc
Failed Impurities/Degradation Specifications
Frequently Asked Questions
What is Nelarabine used for?
Nelarabine is a nucleoside metabolic inhibitor given by intravenous injection that is used to treat certain types of leukemia and lymphoma, particularly in patients who have not responded to other treatments. It works by interfering with cancer cell growth and division.
Is Nelarabine a controlled substance?
Nelarabine is not classified as a controlled substance by the DEA.
What is the generic name for Nelarabine?
The generic name for Nelarabine is Nelarabine. There are 5 other brand versions of Nelarabine.
What is the NDC code for Nelarabine 5 mg/mL?
The NDC (National Drug Code) for Nelarabine 5 mg/mL is 68083-233, listed by Gland Pharma Limited.